Shanxi Bethune Hospital
2 clinical trials · 2 recruiting · OTHER
Trials by Shanxi Bethune Hospital
RECRUITINGNCT07497165
Epunamin Combined With DECP for Relapsed/Refractory Multiple Myeloma
Background: Multiple Myeloma remains an incurable hematologic malignancy, and outcomes for relapsed/refractory multiple myeloma (RRMM) remain unsatisfactory despite advances in...
Sponsor: Shanxi Bethune HospitalEnrolling: 481 location
Relapsed/Refractory Multiple Myeloma (RRMM)Multiple Myeloma
RECRUITINGNCT06783816
A Novel CAR-T Combined Expression of IL-15 in the Treatment of Malignant Hematological Tumors
The is a multicenter, single arm, open label clinical study on the novel CAR-T combined expression of IL-15 in the treatment of malignant hematological tumors.Plan to recruit 45...
Sponsor: Shanxi Bethune HospitalEnrolling: 451 location
Acute Lymphocytic LeukemiaLymphoma,Non-HodgkinRelapsed Refractory Multiple Myeloma